Klara Klein, MD, PhD
Assistant Professor
University of North Carolina at Chapel Hill
Featured in the Session: Using Genetics to Elucidate Atypical Diabetes
When
Saturday, June 6
at 8:00 a.m.
Where
R05 (Level 2)
Ernest N. Morial Convention Center
What is your presentation about?
This presentation describes work that characterizes participants in the Rare and Atypical Diabetes Network (RADIANT) who were referred for clinical monogenic diabetes testing. Diagnosis of monogenic diabetes often allows for targeted therapy and identification of affected relatives, but monogenic diabetes is underdiagnosed. These data underscore the continued challenge to establish a monogenic diabetes diagnosis and highlights key barriers to the diagnosis.
How do you hope your presentation will impact diabetes research or care?
We hope these data will continue to shed light on the importance of monogenic diabetes testing by increasing awareness of monogenic diabetes. Perhaps more importantly, we hope that it will continue to highlight the need for better understanding of how to obtain genetic testing and better insurance coverage!
How did you become involved with this area of diabetes research or care?
I am an investigator in the Rare and Atypical Diabetes Network, which is an incredible consortium of diabetologists, geneticists, and study team members who are interested in better understanding causes of unusual diabetes. This nationwide study is making important new discoveries that have the potential to establish a precision medicine approach to diabetes.